LGALS3 and metabolic dysfunction-associated steatohepatitis: Jin et al. [36] showed that isoquercetin regulated galectin-3-mediated insulin resistance and lipid metabolism in liver cells and provided protection against hepatic steatosis in mice with non-alcoholic steatohepatitis (NASH).